A peripheral blood-based approach involving vimentin along with AURKA enabled efficient tracking of elusive Oct4/Sox2-expressing disseminated breast cancer stem cells
{{output}}
A major impediment in the therapeutic success of breast cancer (BC) arises from persistence of clinically undetectable stem cells (BCSCs) that needs addressal by targeting translationally relevant markers to restrain relapse. Aurora Kinase A (AURKA), due to it... ...
